Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
GeneCode AS Logo
GeneCode AS Growth Score
86
CB Rank
115381
Heat Score
44
GeneCode AS creates new disease-modifying pharmaceuticals.
Founded
obfuscation
PrivateVenture - Series Unknown Tallinn, Harjumaa, Estonia1-10 genecode.com
Pharmaceutical
Overview

GeneCode AS
Total Funding
obfuscation
Growth Score
86
Heat Score
44

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score86
-6 pts
in past quarter
Heat Score 44
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About GeneCode AS

CB Rank
115381
GeneCode AS creates new disease-modifying pharmaceuticals.
Founded
obfuscation
PrivateVenture - Series Unknown Tallinn, Harjumaa, Estonia1-10 genecode.com
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name GeneCode, Ltd.
Operating Status Active
Company Type For Profit
About the Company
GeneCode AS creates new disease-modifying pharmaceuticals.
Contact Email info@genecode.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

GDNF Mimetics Platform
A platform developing small molecule mimetics of Glial cell line-Derived Neurotrophic Factor (GDNF) for treating neurodegenerative diseases.
Parkinson's Disease Drug Development Project
A drug development program focused on creating treatments to slow or stop neurodegeneration in Parkinson's disease.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown
obfuscation
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
1
obfuscation
EIC AcceleratorVenture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EIC Accelerator Logo
EIC Accelerator
Yes
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
—
EIC Accelerator Logo
EIC Accelerator
Yes
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
—
EIC Accelerator Logo
EIC Accelerator
Yes
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
—
EIC Accelerator Logo
EIC Accelerator
Yes
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
—
EIC Accelerator Logo
EIC Accelerator
Yes
Venture Round - GeneCode AS Logo
Venture Round - GeneCode AS
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•Jul 6, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

60
-53.85%
 in past month

Active Website Tech Count

3GeneCode AS is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 5m.

Total IP

2The intellectual property of GeneCode AS includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is GeneCode AS's headquarters? GeneCode AS is located in Tallinn, Harjumaa, Estonia.Who invested in GeneCode AS? GeneCode AS has 2 investors including EIC Accelerator and  EIC Accelerator.When was the last funding round for GeneCode AS? GeneCode AS closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are GeneCode AS's competitors? Alternatives and possible competitors to GeneCode AS may include Coya Therapeutics, Amylyx Pharmaceuticals, and  Asklepios BioPharmaceutical.How much funding has GeneCode AS raised to date? GeneCode AS has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|